Aclaris therapeutics to participate in the 2024 cantor global healthcare conference

Wayne, pa., sept. 10, 2024 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in a fireside chat during the 2024 cantor global healthcare conference on tuesday, september 17, 2024 at 8:00 am et in new york, new york.
ACRS Ratings Summary
ACRS Quant Ranking